Implementing a PROACTive Care Pathway to Empower and Support Survivors of Breast Cancer
- PMID: 37307673
- PMCID: PMC10332840
- DOI: 10.1200/OP.23.00016
Implementing a PROACTive Care Pathway to Empower and Support Survivors of Breast Cancer
Abstract
Purpose: Optimal comprehensive survivorship care is insufficiently delivered. To increase patient empowerment and maximize the uptake of multidisciplinary supportive care strategies to serve all survivorship needs, we implemented a proactive survivorship care pathway for patients with early breast cancer at the end of primary treatment phase.
Methods: Pathway components included (1) a personalized survivorship care plan (SCP), (2) face-to-face survivorship education seminars and personalized consultation for supportive care referrals (Transition Day), (3) a mobile app delivering personalized education and self-management advice, and (4) decision aids for physicians focused on supportive care needs. A mixed-methods process evaluation was performed according to the Reach, Effectiveness, Adoption, Implementation and Maintenance framework including administrative data review, pathway experience survey (patient, physician, and organization), and focus group. The primary objective was patient-perceived satisfaction with the pathway (predefined progression criteria for pathway continuation ≥70%).
Results: Over 6 months, 321 patients were eligible for the pathway and received a SCP and 98 (30%) attended the Transition Day. Among 126 patients surveyed, 77 (66.1%) responded. 70.1% received the SCP, 51.9% attended the Transition Day, and 59.7% accessed the mobile app. 96.1% of patients were very or completely satisfied with the overall pathway, whereas perceived usefulness was 64.8% for the SCP, 90% for the Transition Day, and 65.2% for the mobile app. Pathway implementation seemed to be positively experienced by physicians and the organization.
Conclusion: Patients were satisfied with a proactive survivorship care pathway, and the majority reported that its components were useful in supporting their needs. This study can inform the implementation of survivorship care pathways in other centers.
Conflict of interest statement
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (
 
 
 
 
 
 
 
 
 
 
 
No other potential conflicts of interest were reported.
Figures
 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                References
- 
    - Shapiro CL: Cancer survivorship. N Engl J Med 379:2438-2450, 2018 - PubMed
 
- 
    - Siegel RL, Miller KD, Fuchs HE, et al. : Cancer statistics, 2022. CA Cancer J Clin 72:7-33, 2022 - PubMed
 
- 
    - Ferreira AR, Di Meglio A, Pistilli B, et al. : Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: A prospective patient-reported outcomes analysis. Ann Oncol 30:1784-1795, 2019 - PubMed
 
Publication types
MeSH terms
LinkOut - more resources
- Full Text Sources
- Medical
 
        